Monoclonal Antibody Discovery for Research, Therapeutics and Diagnostics
Since our inception in 1995, Fred Hutch’s Antibody Technology shared resource core has worked with research teams inside and outside the Hutch to design campaign strategies for the generation and identification of novel monoclonal antibody compositions. Our projects encompass a range of applications in oncology, viral therapeutics and diagnostics.
Antibody Discovery
We offer full-service hybridoma antibody discovery through mouse and rat immunization. We have experience immunizing a number of different immunogens including: hapten and peptide conjugates, proteins, mRNA and cellular immunizations.
Antibody Production
We offer scalable productions from hybridoma cultures ranging from 5 mg to 2 grams of research grade antibody. We also offer recombinant antibody expression from Expi293 expression system.
Antibody Characterization
Our characterization services include isotyping, variable domain sequencing, binding kinetics and epitope binning using surface plasmon resonance.
Our Team at Work
We work with researchers to meet each project’s specific objectives. Guided by our team’s combined experience and our commitment to scientific excellence, we will assist you in designing and executing the appropriate strategy for producing the reagent you need.
40
7500
>50
How to Reach Us

Eric Tam
For service requests or other questions: Please submit an inquiry.